Cimex Lectularius or Bed Bugs : Vector of Infectious Agents and Pathogenic Role

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

135 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-03-31

Study Completion Date

2019-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

During the last years, the investigators were the witness to the increase of a old emerging pest due to bed bugs (Cimex lectularius) in the world. Insecticides resistances apparitions and internationals transports increases seem to be the reasons of the pest. Cimex lectularius as vector of parasites, bacteria or virus was often suggested although not much observation are recently investigated in France. This study intends to examine the vectorial ability and the direct pathogenicity of Cimex lectularius.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Assessment of Burden Disease in Patients With Mast Cell Disorders

NCT04615663

Mastocytosis Cutaneous

UNKNOWN

New Therapies and Biomarkers for Chagas Infection

NCT03981523

Trypanosoma Cruzi Infection Chagas Disease

COMPLETED PHASE2

Implementation and Evaluation of Vector Control Methods in Kinshasa: The Case of Aedes

NCT06981442

Aedes-borne Diseases

RECRUITING NA

Congenital Chagas Disease: Long Term Follow up of Treated Children. Preliminary Report or Cardiological Evaluation in Chagas Disease Treated Children

NCT04090489

Chagas Disease Chagas Cardiomyopathy

COMPLETED

Post-treatment Effects of Ivermectin (IVM) or Diethylcarbamazine (DEC) in Loiasis

NCT01593722

Loiasis

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sting

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Collection of the bedbugs and dermatological follow-up of the stings

Collection of the bedbugs and dermatological follow-up of the stings at J1 J7 J14 J21 J28

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* On the site of takings presence of insects and eggs evoking bedbugs of beds. The identification of certainty will be made in the laboratory. All the insects not apartment to the family of Cimicidae (Criterion of exclusion) are thrown(cast) in trash cans of laboratories for organic products.
* voluntary Patients after reading of the information sheet and the signature of the consent
* Membership of the patient in the national insurance scheme

Exclusion Criteria

* On the site of takings absence of insects and eggs evoking bedbugs of beds
* During the identification of certainty in the laboratory, the captured insects do not make parties of the family of Cimicidae
* The subjects deprived of freedom.
* Patients cancelling their consent.
* Patients violating the protocol of search(research)

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes